Rich nations have cornered half of future COVID-19 vaccine supply: Oxfam

The non-governmental organisation analysed deals struck by pharmaceuticals and vaccine producers for the five leading vaccine candidates currently in late-stage trials, based on data collected by the analytics company Airfinity.

Read the full story: Read More